Safety and Efficacy of Encorafenib, Binimetinib, and Cetuximab for BRAF V600E-Mutant Metastatic Colorectal Cancer: Results of the Japanese Expanded Access Program
Titel:
Safety and Efficacy of Encorafenib, Binimetinib, and Cetuximab for BRAF V600E-Mutant Metastatic Colorectal Cancer: Results of the Japanese Expanded Access Program